The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Enfortumab vedotin in the previously treated advanced head and neck cancer (HNC) cohort of EV-202.
 
Paul Swiecicki
Honoraria - Elevar Therapeutics; Seagen
Research Funding - Ascentage Pharma Group
 
Emrullah Yilmaz
Consulting or Advisory Role - Astellas Pharma
 
Ari J. Rosenberg
No Relationships to Disclose
 
Takao Fujisawa
Honoraria - Merck Serono
 
Justine Yang Bruce
Stock and Other Ownership Interests - ImageMoverMD (I)
Consulting or Advisory Role - IDEAYA Biosciences; Istari Oncology; Kura Oncology; Lilly; Merck; OncLive/MJH Life Sciences
Research Funding - Astellas Pharma (Inst); Incyte (Inst); Kura Oncology (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst); Sensei Biotherapeutics (Inst)
 
Changting Meng
Employment - Karyopharm Therapeutics; Seagen
Stock and Other Ownership Interests - Karyopharm Therapeutics; Seagen
Travel, Accommodations, Expenses - Karyopharm Therapeutics; Seagen
 
Michele Wozniak
Employment - Astellas Pharma
 
Lu Wang
Employment - Astellas Pharma
 
Seema Rao Gorla
Employment - Astellas Pharma
Research Funding - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma
 
Jessica Lyn Geiger
Consulting or Advisory Role - Astellas Pharma; Exelixis; Merck; Regeneron
Research Funding - Alkermes (Inst); Genentech/Roche (Inst); Merck (Inst); Merck Serono (Inst); Merck Serono (Inst); Regeneron (Inst)